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Background: Mammography, the gold standard for breast cancer screening misses some cancers, especially in
women with dense breasts. Breast ultrasonography as a supplementary imaging tool for further evaluation of
symptomatic women with mammographically dense breasts may improve the detection of mass lesions otherwise
missed at mammography.
The purpose of this study was to determine the incremental breast cancer detection rate using US scanning in
symptomatic women with mammographically dense breasts in a resource poor environment.
Methods: A cross sectional descriptive study. Women referred for mammography underwent bilateral breast
ultrasound, and mammography for symptom evaluation. The lesions seen by both modalities were described using
sonographic BI-RADS lexicon and categorized. Ultrasound guided core biopsies were performed. IRB approval was
obtained and all participants provided informed written consent.
Results: In total 148 women with mammographically dense breasts were recruited over six months. The prevalence
of breast cancer in symptomatic women with mammographically dense breasts was 22/148 (15%). Mammography
detected 16/22 (73%) of these cases and missed 6/22 (27%). The six breast cancer cases missed were correctly
diagnosed on breast ultrasonography. Sonographic features typical of breast malignancy were irregular shape,
non-parallel orientation, non circumscribed margin, echogenic halo, and increased lesion vascularity (p values < 0.005).
Typical sonofeatures of benign mass lesions were: oval shape, parallel orientation and circumscribed margin
(p values <0.005).
Conclusion: Breast ultrasound scan as a supplementary imaging tool detected 27% more malignant mass lesions
otherwise missed by mammography among these symptomatic women with mammographically dense breasts.
We recommend that ultra sound scanning in routine evaluation of symptomatic women with mammographically
dense breasts.
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Breast cancer is common in women and a leading cause
of cancer mortality in women world wide [1]. In Uganda
breast cancer is the third most common cancer in
women after cervical cancer and Kaposi’s sarcoma [2].
The incidence of breast cancer in Uganda has nearly tri-
pled from 11:100,000 in 1961 to 31:100,000 in 2006 [3].
Breast cancer cases in sub Saharan Africa present in
relatively young women, mostly late in stage III and IV,
run an aggressive course and carry a low 5 year survival* Correspondence: okellojimmy@hotmail.co.uk
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unless otherwise stated.rate of 39% [4]. Reasons for the early nature of cancer
presentation in Uganda is not wholly understood. How-
ever multiple factors presumably responsible for this na-
ture of cancer presentation includes genetics, health
seeking behaviour and short life span among others.
Mammography as the gold standard imaging method
for breast cancer screening in unison with advances in
treatment has resulted in reduced breast cancer mortal-
ity in the western societies; however this has not been
appreciated in resource limited countries like Uganda
where access to functioning mammography units and
trained personnel is limited. Dense breast tissue has
been proven to be the most important inherent limitationThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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some cancers are missed, often requiring ultrasound to
complete the breast imaging assesment [5]. In addition
dense fibroglandular tissue per se is associated with in-
creased risk of breast cancer and also lowers the sensitivity
of mammography to as low as 30-48% [6].
Methods
Design
A cross sectional descriptive study.
Setting
We conducted this study between 1st February to 30th
August at Mulago Hospital, the National Referral and a
Teaching Hospital for Makerere University located in
Kampala, Central Uganda. It has a capacity of 1,500
beds. Mulago Hospital Radiology Department has one
functional mammography unit which is uses computed
radiography technology to produce digital mammo-
graphic images, its open from Monday from Friday and
receives patients referred from breast clinics within
Mulago as well as the other private hospitals within and
outside the city. About 5 diagnostic mammograms were
performed daily. The hospital has a functional pathology
department offering diagnostic laboratory services managed
by experienced pathologists. A female mammographer with
a-15-years experience performed the mammograms. The
mammograms, breast ultrasound scans and image inter-
pretation as well as US guided core biopsies were per-
formed by a team of consultant radiologists and residents
in accordance with the BI-RADS atlas.
Inclusion criteria
Women 25 years and above with mammographically
dense breasts who consented to participate in the study
were included. However, women taking hormone re-
placement therapy were excluded.
Sampling and data collection
Women referred for mammography were x-rayed in ac-
cordance with the cut off age spelt in the Uganda breast
cancer clinical guidelines. Those with mammographically
dense breasts were consecutively recruited upon obtaining
an informed written consent to participate in the study.
Data was collected using a pre-coded and pre tested
questionnaire. Study variables included;
Socio-demographic data such as Age, gender, meno-
pausal status, indication for mammography, mass lesion
visibility on mammogram, Sonographic BI-RADS de-
scriptors, BI-RADS final assessment categorization as
well as histological diagnosis.
The mammograms were performed using Phillips
Mammogram diagnost UC model 2000 with a dual focal
spot 0.3/0.1 mm acceptable for both diagnostic andscreening purpose. 18 × 24 cm imaging plates with a single
intensifying screen for computed radiography. Philips Com-
puted Radiography computer system with its laser printer.
A Philips HD7 2009 model manufactured by Philips
and Neusoft Medical systems Co. Ltd, Shenyang, China,
with a 7. 5 to12 MHz broad band linear probe were used
to scan the patients.
US-guided core biopsies were performed using needle
gauze 14.
Standard mammographic views (Mediolateral oblique
and Craniocaudal views) were performed in accordance
with the international atomic energy agency (IAEA) hu-
man health series [18]. The imaging plates were then
processed using the computed radiography system inor-
der to print CR mammograms. The mammograms were
subsequently viewed systematically on a dedicated mam-
mographic film viewer box by a team that consisted of
the Consultant Radiologists and radiology residents. The
mammographic breast density category was categorized
according to the ACR BI-RADS atlas breast density cat-
egories recorded as 1,2,3 or 4. The final conclusion
reached on consensus by the team on the breast density
category and final mammographic diagnosis was docu-
mented on the questionnaire by the principle investiga-
tor. The BI-RADS atlas was available to the team and
was helpful in sorting out interobserver disagreements
that arose during interpretation.
Bilateral whole breast ultrasound scan was performed
on all the study participants for atleast one of the follow-
ing reasons;
Further evaluation of mammographically dense breast
tissue inorder to complete breast image work up or
ultrasound guided biopsy of the detected breast lesions
when indicated.
The process of breast sonographic examination was ex-
plained to the patient before performing it. While observing
privacy in the examination room all patients had to change
to a clean examination gown with adequate exposure of
chest wall. A chaperone was present during the procedure.
The patients were positioned lying supine oblique on a
clean examination bed with the ipsilateral hand extended
above the head to stabilize and flatten breast against the
chest wall. This positioning was done for both breasts.
An acoustic gel was applied on the breast prior to
scanning using the linear probe.
Both breasts were systematically scanned with over-
lapping scans in a radial and antiradial pattern from the
nipple to the periphery. The retroareolar region inclu-
ding both axillae were scanned separately with angled
probe views to ensure the complete coverage of all
breast tissue. The images were saved as a soft copy in
the US machine and copied to DVD blanks. A hard copy
print on thermal paper was also made for some
patients.
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down in accordance with the BI-RADS US lexicon
adapted from the American college of radiology for
standardization and given to the study participants.
Sonographs were blinded to the mammograph results.
A total of 45 US guided core biopsies were performed
on breast mass lesions categorized as BI-RADS final as-
sessment categories 4, 5 as well as some category 3 cases.Biopsy procedure
An informed consent for biopsy was obtained after thor-
ough explanation of the procedure to the study patients.
Both breasts including the axillae were systematically
scanned with overlapping scans in a radial and antiradial
pattern until a mass lesion was localized.
Under local anaesthesia and aseptic technique ultra-
sound guided core needle biopsy of solid breast masses
were performed by a standard free hand technique using a
disposable automated 14-gauge needle with a 22 mm
throw. The breast tissue sampled was put in a biopsy bot-
tle containing formalin and taken for histopathological
analysis. At least 3 biopsy samples was taken from each le-
sion for diagnostic adequacy of the sample.
In case the lesions were sonographically similar then
only one of the most prominent lesions was biopsied.
If the lesions are sonographically differing in appear-
ance then at least two of the lesions were biopsied.
Ultrasound guided fine-needle aspiration biopsy was
done for complex cysts or masses, sample was air dried
for 5 seconds prior to fixing it on the slide using ethanol
95% solution.
We took the biopsy samples to pathology laboratory
for cytopathological analysis.Data management
Questionnaires were checked for completeness. Data
was entered into the computer using EPI DATA version
3.1. It was exported to STATA version 2013 for analysis.
Statistical methods to analyze the data included univari-
ate, bivariate analyses. Categorical and nominal variables
were summarized using proportions, frequency tables,
pie chart, and histograms.Quality control
Quality control was ensured using the following measures:
The questionnaire was pre tested before commence-
ment of the study to ascertain if the required informa-
tion could be obtained using the specified questions.
Breast imaging interpretation was performed by a
team, with BI-RADS atlas [12] available for reference to
ensure correct interpretation was made.Ethical consideration
Approval was obtained from Makerere University College
of Health Sciences and IRB of Mulago Hospital.
Patient confidentiality was ensured.
Results
Out of the total 370 mammograms performed, 148 were
categorized as BI-RADS density category 3 or 4 (mam-
mographically dense breast tissues) and all underwent
bilateral breast ultrasound scan. A total of 111 lesions were
detected and described using the BI-RADS lexicon and
final assessment categorization was made. US guided biopsy
was done for 43 patients with BI-RADS final assessment
category 4 or 5 lesions. 2 patients with breast masses cate-
gorized as BI-RADS 4 were not biopsied as they did not re-
turn for their biopsy appointment (see Figure 1).
The characteristics of lesions missed on mammog-
raphy are indicated in Table 1.
Several BIRADS sonographic descriptors were used and
included shape, orientation margins, boundaries, echo tex-
ture, posterior acoustic feature, surrounding tissues, calci-
fication, lesion vascularity size and lymph nodes. Shape,
orientation, margins, boarders and vascularity differenti-
ated between benign and malignant, see Table 2.
In Figure 2 we show the presenting complaints; a lump
being the most prevalent, followed by breast pain.
Figure 3A and B mammogram show a sample of a
BIRADS 3 density. The mammogram shows BI-RADS
density category 3 and no focal mass is demonstrable.
Figure 4 shows a sonogram of a solid mass with de-
scriptors suggesting a malignancy is shown.
US guided biopsy revealed a poorly differentiated infil-
trative lobular carcinoma.
Majority of the women were symptomatic with palp-
able breast lump. Only two women came for breast can-
cer screening.
Diagnostic performance of US scan and mammogram
is described and shown in Table 3.
The most frequent histological type was ductal carcin-
oma 54% followed by lobular carcinoma. The most com-
mon benign lesions were firoadenomas (see Table 4).
In all 22 breast cancer cases were correctly diagnosed
using sonography and occurred in relatively young women
averaging to 41 years in age (age range; 28-59 years),
see Table 4.
Discussion
We set to investigate the incremental breast cancer de-
tection rate of breast ultrasonography as a supplemental
imaging tool in evaluation of symptomatic women with
dense breasts (BIRADS 3 & 4). We found that US Scan
detected 27% more malignant lesions than mammog-
raphy did. The odds of mammography missing a malig-
nant breast lesion in dense breasted women were 1 in 4.
Figure 1 Study flow chart showing participants recruitment and outcomes.
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widest diameter. Reasons for missing these malignant mass
lesions could be the dense tissues obscuring visualization
of those small sized tumors at mammography. However all
the missed lesions were detected at US scan which is not
limited by breast density. These findings are important be-
cause small lesions (less than 20 mm) are mostly early
breast cancer lesions and are amenable to curative treat-
ment. In addition ultrasound is more accessible than
mammogram in our environment, therefore becomes an
attractive supplement to mammography [3].
The BI-RADS sonographic lexicon was helpful in dis-
tinguishing benign from malignant solid breast masses
with typical signs of malignancy being irregular shape,
anti-parallel orientation, non circumscribed margin,
echogenic halo, and increased lesion vascularity. Typical
signs of benignity were oval shape and circumscribed
margin (p < 0.005).Table 1 Characteristics of the mammographically missed canc
Cases Age Complaint BI-RADS densit
1 45 Pain 3
2 31 Lump 4
3 28 Lump 4
4 35 Lump 4
5 38 Discomfort 3
6 29 Painful lump 4Mass echo texture, posterior acoustic features and
surrounding tissues of a mass as well as presence or
absence of lymph nodes were not reliable in differenti-
ating between benign and malignant mass lesions (P >
0.005).
A total malignancy rate of 14.9% (22/148) is three fold
higher compared to a previous study by Paulo et al. which
showed a prevalence of 4.2% among symptomatic patients
with dense mammograms [16].
Breast cancer occurred in relatively young women
averaging to 41 years in age (age range; 28-59years). This
finding is in keeping with literature which shows that
more than half of women between 25 and 49 years of
age have dense breasts with more cancer risks, as do ap-
proximately 29% of women older than 50 years [4,5].
Nearly all the women were symptomatic; 99% (n =
146) and only two women (1%) came in for breast can-
cer assessment.er cases
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Oval 15 (13.9) 2 (13.3) 13 (86.7)
Round 50 (46.3) 25 (50.0) 25 (50.0)
Irregular 43 (39.8) 41 (95.4) 2 (4.6)
Orientation 0.001
Parallel to skin 67 (62) 13 (19.4) 54 (80.6)
Not parallel 41 (38) 40 (97.6) 1 (2.4)
Margin <0.001
Circumscribed 53 (49.1) 5 (9.4) 48 (90.6)
Non circumscribed 55 (50.9) 52 (94.5) 3 (5.5)
Lesion boundary 0.004
Abrupt interface 80 (74.1) 53 (66.3) 27 (33.7)
Echogenic halo 28 (25.9) 26 (92.8) 2 (7.2)
Echo texture 0.448
Anechoic 14 (13.0) 7 (50.0) 7 (50.0)
Hypoechoic 74 (68.5) 53 (71.6) 21 (28.4)
Complex 17 (15.7) 16 (94.1) 1 (5.9)




No posterior feature 40 (37.0) 24 (60.0) 16 (40.0)
Enhancement 32 (29.6) 21 (65.6) 11 (34.4)
Shadowing 18 (16.7) 17 (94.4) 1 (5.6)
Combined 18 (16.7) 16 (88.9) 2 (11.1)
Surrounding tissues 0.448
Normal 65 (60.2) 15 (23.1) 50 (76.9)
Architectural distortion 20 (18.5) 19 (95.0) 1 (5.0)
Skin thickening 11 (10.2) 7 (63.6) 4 (36.4)
Subcutaneous oedema 11 (10.2) 8 (72.7) 3 (27.3)
Nipple retraction 1 (0.9) 1 (100.0) 0 (0.0)
Calcification 0.406
Micro calcification 35 (32.4) 34 (97.1) 1 (2.9)
Macro calcification 2 (1.9) 2 (100.0) 0 (0.0)




41 (37.9) 37 (90.2) 4 (9.8)
Avascular 56 (51.9) 29 (51.8) 27 (48.2)
Increased surrounding
vascularity
11 (10.2) 9 (81.8) 2 (18.2)
Table 2 Frequency of BI-RADS sonographic descriptors





<1 cm 6 (5.6) 1 (16.7) 5 (83.3)
1-2.5 cm 44 (40.7) 27 (61.4) 17 (38.6)




Present 73 (67.6) 60 (82.2) 13 (17.8)
Absent 35 (32.4) 19 (54.3) 16 (45.7)
Note: Numbers in parentheses are percentages of each group.
Frequency: Number of times this US feature was reported to be present.
Malignant outcome = number of masses reported to have this feature that
were considered malignant.
Benign outcome = number of masses reported to have this feature that
were benign.
NA = Not applicable as the US feature is not a recognized BI-RADS descriptor
according to ACR.
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pearance on mammography, making it difficult to distin-
guish metabolically active normal breast tissue from
cancer. As a result, the performance of mammography
in women with high breast density is poor [3,6-10]. The
relative availability of ultrasound makes it an attractive
imaging modality for evaluating women for breast can-
cer in resource-limited settings where other modalities
like MRI are not readily available.
Correlation of sonographic features with benign versus
malignant outcome
A standardized lexicon for sonography was developed in
2003 by the ACR in light of the increasing use ofFigure 2 The main presenting complaint of the study patients.
Figure 3 Mammographic films of a 31-year old woman who presented with a palpable left breast lump for 4 months, A: Oblique views
B: craniocaudal views.
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counterpart, the sonographic BI-RADS lexicon was
intended to provide a unified language for sonographic
reporting and research and to avoid ambiguity in the
communication and teaching of sonographic interpret-
ation [12]. This lexicon helps the radiologist in describing
sonographic features and defining the final assessment cat-
egory that is associated with the most appropriate clinical
management of the case.
Sonographic BI-RADS descriptors that most reliably
characterized a mass as malignant study include an ir-
regular shape, non circumscribed margin, non parallel
orientation, echogenic halo around a mass, and in-
creased vascularity within the mass.
In this study, Sonographic BI-RADS descriptors highly
predictive of benignity of a mass were circumscribed
margin; 90.6% (48/53), parallel orientation; 80.6% (54/67),
and oval shape; 86.7 (13/15). Bi-variate analysis of these
descriptors (margin, shape, orientation, lesion boundary
and vascularity chosen were significantly reliable in differ-
entiating malignant and benign (p < 0.005).
This is in conformity with prior study findings that,
these BI-RADS descriptors represent an abnormal dis-
ease process in the breasts [11,13].Figure 4 Sonogram shows a solid hypoechoic mass which is
irregular in shape, has angular margin with surrounding
echogenic halo at 11 O’clock 5 cm from right nipple.A circumscribed margin is well defined or sharp, with
an abrupt transition between the lesion and surrounding
tissue usually predicts a benign outcome.
As in mammography, sonographic evidence of non cir-
cumscribed margins (which includes one of these op-
tions: spiculated, angular, microlobulated and indistinct
margins) suggests infiltrating growth of the lesion into
the surrounding tissue which is most times predictive of
a malignant outcome.
Irregular shapes indicate inconsistent growth and ad-
vancement of the lesion edge which usually predicts a
malignant outcome while for a benign mass usually takes
on an oval or a round shape.
A parallel orientation is when the long axis of lesion
parallels the skin line (“wider than tall” or horizontal)
whereas a non-parallel orientation refers to a long axis,
not oriented along the skin line (“taller than wide” or
vertical, includes round masses).
Non-parallel orientation on sonography may suggest
spread of the lesion through tissue-plane boundaries, a
characteristic which is more likely to be associated with
malignant lesions. In contrast, circumscribed margins
and oval shapes represent smooth uniform growth with-
out involvement of surrounding tissue and are associated
more with a benign lesion. Similarly, parallel orientation
suggesting containment in one tissue plane and indica-
tive of a benign process.
Lesion boundary refers to the demarcation between
the mass lesion and surrounding tissues. Identification
of surrounding echogenic halo was a reliable BI-RADS
descriptor in predicting a malignant outcome in this
study. This agrees with previous studies which showed
that identification of surrounding tissue effects had a
high predictive value for malignancy, suggesting that
recognition of such features could be helpful in the final
assessment categorization at ultrasonography [12,13].
Increased vascularity within a mass lesion was a reli-
able BI-RADS descriptor of malignancy, a finding that
agrees with literature.
Mass echo texture, posterior acoustic features and sur-
rounding tissues of a mass as well as presence or absence
Table 3 Diagnostic performance of mammography versus ultrasound in visualizing mass lesion in women with




Mammogram Ultrasound Mammographic findings Ultrasound plus Mammographic findings;
(BI-RADS final assessment)
Conclusive diagnosis Conclusive diagnosis
Frequency; N (%) Frequency; N (%) Frequency; N (%) Frequency; N (%)
Yes 69 (62.2) 110 (99.1) 71 (64) 111 (100)
No 42 (37.8) 1 (0.9) 40 (36) 0 (0)
Total 111 100 111 100
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tween benign and malignant mass lesions in this study.
The most common malignancy was invasive ductal car-
cinoma which accounted for 54.5% (n = 12) of histopatho-
logical examination results obtained. This histopathological
finding confers with previous studies [14,15]. The cancer
yield is comparable to the expected rate of malignancy in
BI-RADS final assessment categories. Benign breast disease
was also not uncommon with fibroadenoma being the most
commonly encountered histological diagnosis.
Several factors limit the use of mammography in
breast cancer detection in Uganda. First, breast cancer
peaks in younger women who more frequently have
denser breasts and, therefore the sensitivity of mammog-
raphy is reduced. Second, younger women [17] are more
sensitive to ionizing radiation. Several other benefits to
using ultrasound include its relatively cheaper costs, its
availability in resource-limited countries, no limitation
by fibroglandular breast composition, its ability to be
used for image guided-biopsies with relatively little add-
itional training and equipment, and its portability [7-9].
For these reasons, ultrasound is an attractive imaging
modality for evaluating women for breast cancer in aTable 4 Breast lump histological diagnoses
Breast cancer cases
Histological type Frequency; N (%)
Invasive ductal carcinoma 12 (54)
Infiltrating lobular carcinoma 2 (9)
Adeno carcinoma 6 (27)
Lymphoma 1 (5)
Alveolar rhabdomyosarcoma 1 (5)
Total 22 (100)
Benign breast conditions
Fibro adenoma 7 (33)
Cystic mastopathy 4 (19)
Chronic inflammation 5 (24)
Sclerosis adenosis 1 (5)
Other benign conditions 4 (19)
Total (benign conditions) 21 (100)resource-limited country such as Uganda. According to
the latest BI-RADS atlas, it is mandatory that a mammo-
graphically dense breast tissue needs further additional
imaging evaluation in order for the interpreting radiolo-
gist to make a conclusive radiological diagnosis. This
further imaging evaluation is most times completed
using high frequency breast ultrasound and rarely re-
quiring MRI scan [10]. The are only five mammography
machines which are inequitably distributed in Uganda
compared to over 100 high frequency range ultrasound
machines capable of breast sonography. This study was
carried out with the aim of evaluating the use of bilateral
whole breast ultrasound scan as an adjunctive imaging
tool to detect cancer in women with dense breasts at
Mulago hospital. Breast mass lesions detected were de-
scribed according to the BI-RADS lexicon and final as-
sessment categorization made.Study limitations
This was a cross sectional descriptive study and so short
term interval follow up of breast mass lesions categorized
as benign and probably benign (BI-RADS 2 and BI-RADS
3 respectively) was not carried out to ascertain radiological
and clinical stability of these mass lesions. Not all benign
breast lesions were biopsied hence sensitivity and specifi-
city of breast ultrasound could not be calculated.Conclusion
Breast ultrasound scan resulted in significant incremental
breast cancer detection rate (of 27%) among symptomatic
women with mammographically dense breast tissue. We
recommend that breast ultrasound scan should routinely
be done in mammographically dense breasts (BI-RADS
density category 3 and 4) in resource limited settings.Competing interest
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